Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas

European Journal of Endocrinology

Volumn 146, Issue 2, 2002, Pages 209-213

  García, Juan Luis ^a   Tardío, Juan C ^a   Gutiérrez, Norma Carmen ^a   González, María Belén ^a   Polo, José Ramón ^a   Hernández, Jesús Mara ^a   Menárguez, Javier ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 11; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 8P; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME XQ; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC GAIN; HUMAN; HUMAN TISSUE; MALE; PARATHYROID ADENOMA; PREVALENCE; PRIORITY JOURNAL;

EID: 0036175427     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460209     Document Type: Article

References (34)

1. Monoclonality and abnormal PT hormone genes in parathyroid adenomas
2. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma
3. A novel cyclin encoded by bcl1-linked candidate oncogene
4. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors
5. A possible tumor suppressor gene for parathyroid adenomas
6. Somatic mutation of the MEN1 gene in parathyroid tumors
7. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region
8. Loss of heterozygosity in sporadic parathyroid tumours: Involvement of chromosome 1 and the MEN1 gene locus in 11q13
9. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism
10. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism
11. Parathyroid adenoma with t(1;5)(p22;q32) as the sole clonal chromosome abnormality
12. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas
13. Parathyroid tumor suppressor on 1p: Analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate
14. Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36
15. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas
16. Genetic abnormalities in sporadic parathyroid adenomas: Loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus
17. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas
18. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas
19. Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism
20. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BCRA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumors
21. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
22. Comparative genomic hybridization analysis of human parathyroid tumors
23. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas
24. Alternative genetic pathways in parathyroid tumorigenesis
25. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas
26. Molecular cloning
27. Molecular analysis of chromosome aberrations. In situ hybridization
28. Patterns of chromosomal imbalances in parathyroid carcinomas
29. WAF-1 and MDM2 are frequently overexpressed in parathyroid adenomas
30. Analysis of the cyclin D1/p16/pRB pathway in parathyroid adenomas
31. Genetics aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy
32. ATM is usually rearranged in T-cell prolymphocytic leukaemia
33. Alterations of the PPP2R1B gene in human lung and colon cancer
34. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer